Trethera Announces Appointment of M. Andrew ("Drew”) Woodmansee to Board of Directors
Summary
LOS ANGELES, April 21, 2026 (GLOBE NEWSWIRE) -- Trethera Corporation ('Trethera”), a clinical-stage biopharmaceutical company developing first-in-class therap...
Description
LOS ANGELES, April 21, 2026 (GLOBE NEWSWIRE) -- Trethera Corporation ('Trethera”), a clinical-stage biopharmaceutical company developing first-in-class therap...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source